Evogene Ltd.

General Data

Reg Number
512838723
Sector
Biomed
Established
2002
No. of Employees
125
Stage
Revenue Growth
Additional Funding
0

Technology

The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Castera Ltd.

Targeted Customers

Life sciences, Human health and Agriculture industry.

Management personnel

Ofer Haviv - CEO & President
Mark Kapel - EVP, Technology / CTO
Yaron Eldad - CFO

Contact information

Name
Country
Israel
Zip
7638517

Tags

AgriBiotechAlternative ProteinsArtificial IntelligenceBig DataBiotechnologyComputational BiologyComputational GenomicsLife SciencesMedTechPlant-basedSynthetic Biology

Classified Technologies

Pharma

Winning details

Route name
Winning year